AUS
NZ
UK
CA
USA
IND
Health
Bioscience Inc. (VIVO) agrees to US$1.5 Bn buyout deal
July 08, 2022 07:35 AM PDT| By Mridul GogoiBioscience Inc. (Nasdaq: VIVO) concedes to US$1.5 Bn buyout deal by Seoul-based device maker SD Biosensor Inc. for US$1.53 billion.
NBIX to ITCI: Five mid-cap healthcare stocks to watch in July
July 04, 2022 01:33 PM PDT| By Versha JainHealthcare sector has been in good stead and shown resilience in a bearish market.
NeuroSense (NRSN) stock soars 35% after Alzheimer's study results
June 30, 2022 09:51 AM PDT| By Versha JainNeuroSense stock soared over 35% on Thursday after study results showing potential of its drug combination for Alzheimer's treatment.
Kezar (KZR) stock soars 49% on positive lupus trial results
June 28, 2022 11:31 AM PDT| By Versha JainKezar (KZR) stock soared on the positive top-line data from Mission phase 2 clinical trial.
Acutus (AFIB) stock zooms 100% after FDA clearance
June 27, 2022 09:37 AM PDT| By Versha JainAcutus stock jumped on Monday after getting FDA clearance.
Novartis AG (NVS) stock rises after FDA’s accelerated drug approval
June 23, 2022 09:13 AM PDT| By Versha JainNovartis AG received FDA's accelerated approval for the combination of its two drugs, Tafinlar and Mekinist as first tumor-agnostic indication.
Seagen (SGEN) stock roared 17% higher on Merck’s (MRK) buyout plan
June 17, 2022 11:37 AM PDT| By Versha JainHighlights: Washington-based Seagen Inc. (NASDAQ: SGEN) stock rose 16.76% on Friday. Merck & Company, Inc. (MRK) is considering buying the biotech firm. However, their talks are not yet conclusive. Washington-based Seagen Inc. (.....
Cogent Biosciences (COGT) stock soars 101% on positive trial data
June 10, 2022 11:45 AM PDT| By Versha JainHighlights: Cogent Biosciences, Inc. (NASDAQ: COGT) develops therapies for genetic diseases. The company went public on March 26, 2018. On Friday, it reported positive Phase 2 clinical trial data for ‘Bezuclastinib’. Sha.....
Top healthcare stocks to explore in June: JNJ, LLY, ABBV, MRK & BMY
June 09, 2022 04:38 PM PDT| By Rupam RoyHighlights: Johnson & Johnson (NYSE: JNJ) revenue increased by 5% YoY in Q1, FY22. Merck & Company, Inc. (NYSE: MRK) revenue rose 50% YoY in Q1, FY22. Bristol-Myers Squibb Company (NYSE: BMY) stock returned over 21% gains YTD. The.....
Becton, Dickinson & Co (BDX) to acquire Parata Systems for US$1.525 bn
June 06, 2022 10:08 AM PDT| By Mridul GogoiHighlights: Becton, Dickinson & Company or BD (NYSE: BDX) to acquire Parata Systems for US$1.525 billion. The deal is likely to close by the end of the first half of fiscal 2023 for BD. The pharmacy automation market is set to grow approxi.....
Turning Point (TPTX) stock zooms 115% on Bristol Myers’ (BMY) acquisition
June 03, 2022 11:31 AM PDT| By Versha JainHighlights Turning Point Therapeutics, Inc. (TPTX) is focused on precision oncology therapy. It was founded in 2013 and launched its IPO in April 2019. Bristol Myers Squibb is acquiring Turning Point for US$4.1 billion in equity va.....
Why Immix Biopharma Inc (IMMX) stock soared 55% on Friday?
May 20, 2022 01:21 PM PDT| By Versha JainThe Immix Biopharma Inc. (NASDAQ: IMMX) stock surged 55% after announcing positive results for its lead drug candidate IMX-110 in the first treatment cycle. The stock traded at US$2.5425 at 1:00 pm ET on Friday. The company said that its lead dru.....
MCK to ABC: 5 healthcare stocks that returned strong 1-year, YTD gains
May 13, 2022 11:40 AM PDT| By Versha JainHighlights Bristol-Myers Squibb (NYSE: BMY) has a P/E ratio of 27.0 and a dividend yield of 2.84%. Merck & Company, Inc.'s (NYSE: MRK) P/E ratio is 16.02, and the dividend yield is 3.09%. AbbVie Inc.'s (NYSE: ABBV) dividend yield is .....
Biohaven (BHVN) stock soars 70% after Q1 results, Pfizer’s (PFE) buy offer
May 10, 2022 11:32 AM PDT| By Versha JainHighlights Drugmaker Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) net product revenue grew 182% YoY to US$123.6 million in the quarter ended March 31, 2022. On Tuesday, Pfizer announced acquiring Biohaven for US$11.6 billion .....
BioNTech’s (BNTX) Q1 earnings surge on COVID-19 vaccine sales
May 09, 2022 10:06 AM PDT| By Team Kalkine MediaHighlights: BioNTech (BNTX) reported first-quarter FY-2022 revenues of €6.4 billion (US$6.7 billion). The net income for the first quarter of 2022 for BioNTech remained at €3.7 billion (US$3.9 billion). BioNTech confirms its COVID-19.....
CVS Health reports strong Q1 FY-2022 results to outpace estimates
May 04, 2022 01:12 PM PDT| By Team Kalkine MediaHighlights: CVS Health Corporation beats Wall Street estimates in Q1 2022 earnings report. CVS reported total revenue of US$76.8 billion in Q1 FY-2022. CVS’s GAAP diluted earnings per share (EPS) remained at US$1.74. CVS Health Corp.....
Pfizer (PFE) posts Q1 revenue of US$25.7bn as Comirnaty vaccine shines
May 03, 2022 01:18 PM PDT| By Team Kalkine MediaHighlights: Pfizer Inc. (NYSE: PFE) reported a strong Q1, FY 2022, revenue of US$25.7 billion on Tuesday. Pfizer posted 82% operational revenue growth in the first quarter of 2022. Pfizer’s direct sales of the Comirnaty vaccine grew to .....
Why Vaxxinity Inc. (VAXX) stock zoomed over 80% on Friday?
April 29, 2022 03:17 PM PDT| By Versha JainHighlights Texas-based Vaxxinity is a biotechnology company specializing in vaccines for chronic disorders and infectious diseases. The company launched its IPO in November 2021. The stock price has declined by over 72% since the IPO. .....
Eli Lilly’s (LLY) Q1 revenue grows 15% on obesity drug sales
April 28, 2022 12:21 PM PDT| By Team Kalkine MediaHighlights: Eli Lilly and Company (LLY) reported a 15% revenue growth in the first quarter. Eli Lilly’s Covid-19 vaccine revenue grew to US$660 million. Its key growth products are Tirzepatide, Trulicity, Verzenio, Jardiance, and Taltz. .....
.jpg)
Why Evoke Pharma (EVOK) stock soared 139%?
April 26, 2022 10:56 AM PDT| By Versha JainHighlights Evoke Pharma is a specialty pharmaceutical company focused on drugs for treating gastrointestinal disorders and diseases. The US Food and Drug Administration (FDA) has granted new drug product exclusivity for the company.....
